Cargando…

Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years

INTRODUCTION: Peripherally localized aromatase, which converts circulating androgens into estrogens, is important in the pathogenesis of postmenopausal breast carcinomas. We have previously shown that aromatase mRNA levels are higher in elderly breast carcinomas (EldCa) than breast carcinomas of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Honma, Naoko, Takubo, Kaiyo, Sawabe, Motoji, Arai, Tomio, Akiyama, Futoshi, Sakamoto, Goi, Utsumi, Toshiaki, Yoshimura, Noriko, Harada, Nobuhiro
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750107/
https://www.ncbi.nlm.nih.gov/pubmed/19589174
http://dx.doi.org/10.1186/bcr2335
_version_ 1782172204470894592
author Honma, Naoko
Takubo, Kaiyo
Sawabe, Motoji
Arai, Tomio
Akiyama, Futoshi
Sakamoto, Goi
Utsumi, Toshiaki
Yoshimura, Noriko
Harada, Nobuhiro
author_facet Honma, Naoko
Takubo, Kaiyo
Sawabe, Motoji
Arai, Tomio
Akiyama, Futoshi
Sakamoto, Goi
Utsumi, Toshiaki
Yoshimura, Noriko
Harada, Nobuhiro
author_sort Honma, Naoko
collection PubMed
description INTRODUCTION: Peripherally localized aromatase, which converts circulating androgens into estrogens, is important in the pathogenesis of postmenopausal breast carcinomas. We have previously shown that aromatase mRNA levels are higher in elderly breast carcinomas (EldCa) than breast carcinomas of the control group (ContCa) or normal breast tissues. Aromatase expression has been reported to be regulated through the alternative use of multiple exons 1 (exons 1a-1f and so on); however, the preferential usage of exons 1 in elderly breast tissue has never been systematically examined. In order to properly treat and protect against EldCa, the regulation mechanism of aromatase expression in elderly breast tissues should be elucidated. The aim of the present study is to elucidate whether there are any specific patterns in use of multiple exons 1 in elderly breast tissue. METHODS: Usage of multiple exons 1 of the aromatase gene and mRNA levels of aromatase were examined by reverse transcription-polymerase chain reaction analysis in breast tissues of 38 elderly patients with breast cancer (age 80–99), and the results were compared with those in 35 patients of the control group (age 37–70). One-factor analysis of variance and the Scheffé test were used for the comparison of aromatase mRNA levels. Patterns of preferential utilization of multiple exons 1 of the aromatase gene were compared by χ(2 )test for independence or Fisher exact test for independence using a contingency table. RESULTS: Exon 1d was utilized much more frequently in elderly tissue than in the control group irrespective of cancerous or normal tissue (EldCa, 36/38, 95% versus ContCa, 7/35, 20%, P < 0.0001; normal tissue of the elderly, EldNorm, 30/34, 88% versus normal tissue of controls, ContNorm, 2/29, 7%, P < 0.0001). Twenty EldCa (53%) and 12 EldNorm (35%) used both exons 1c and 1d; however, their dominance was reversed (EldCa, all 1d > 1c; EldNorm, all 1c > 1d). CONCLUSIONS: Elderly breast tissues exhibited specific patterns in use of multiple exons 1, which at least partly explained the higher aromatase levels in EldCa. The mechanisms of how these specific patterns occur during aging and carcinogenesis should be further examined.
format Text
id pubmed-2750107
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27501072009-09-25 Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years Honma, Naoko Takubo, Kaiyo Sawabe, Motoji Arai, Tomio Akiyama, Futoshi Sakamoto, Goi Utsumi, Toshiaki Yoshimura, Noriko Harada, Nobuhiro Breast Cancer Res Research Article INTRODUCTION: Peripherally localized aromatase, which converts circulating androgens into estrogens, is important in the pathogenesis of postmenopausal breast carcinomas. We have previously shown that aromatase mRNA levels are higher in elderly breast carcinomas (EldCa) than breast carcinomas of the control group (ContCa) or normal breast tissues. Aromatase expression has been reported to be regulated through the alternative use of multiple exons 1 (exons 1a-1f and so on); however, the preferential usage of exons 1 in elderly breast tissue has never been systematically examined. In order to properly treat and protect against EldCa, the regulation mechanism of aromatase expression in elderly breast tissues should be elucidated. The aim of the present study is to elucidate whether there are any specific patterns in use of multiple exons 1 in elderly breast tissue. METHODS: Usage of multiple exons 1 of the aromatase gene and mRNA levels of aromatase were examined by reverse transcription-polymerase chain reaction analysis in breast tissues of 38 elderly patients with breast cancer (age 80–99), and the results were compared with those in 35 patients of the control group (age 37–70). One-factor analysis of variance and the Scheffé test were used for the comparison of aromatase mRNA levels. Patterns of preferential utilization of multiple exons 1 of the aromatase gene were compared by χ(2 )test for independence or Fisher exact test for independence using a contingency table. RESULTS: Exon 1d was utilized much more frequently in elderly tissue than in the control group irrespective of cancerous or normal tissue (EldCa, 36/38, 95% versus ContCa, 7/35, 20%, P < 0.0001; normal tissue of the elderly, EldNorm, 30/34, 88% versus normal tissue of controls, ContNorm, 2/29, 7%, P < 0.0001). Twenty EldCa (53%) and 12 EldNorm (35%) used both exons 1c and 1d; however, their dominance was reversed (EldCa, all 1d > 1c; EldNorm, all 1c > 1d). CONCLUSIONS: Elderly breast tissues exhibited specific patterns in use of multiple exons 1, which at least partly explained the higher aromatase levels in EldCa. The mechanisms of how these specific patterns occur during aging and carcinogenesis should be further examined. BioMed Central 2009 2009-07-10 /pmc/articles/PMC2750107/ /pubmed/19589174 http://dx.doi.org/10.1186/bcr2335 Text en Copyright © 2009 Honma et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Honma, Naoko
Takubo, Kaiyo
Sawabe, Motoji
Arai, Tomio
Akiyama, Futoshi
Sakamoto, Goi
Utsumi, Toshiaki
Yoshimura, Noriko
Harada, Nobuhiro
Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years
title Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years
title_full Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years
title_fullStr Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years
title_full_unstemmed Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years
title_short Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years
title_sort alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750107/
https://www.ncbi.nlm.nih.gov/pubmed/19589174
http://dx.doi.org/10.1186/bcr2335
work_keys_str_mv AT honmanaoko alternativeuseofmultipleexons1ofaromatasegeneincancerousandnormalbreasttissuesfromwomenovertheageof80years
AT takubokaiyo alternativeuseofmultipleexons1ofaromatasegeneincancerousandnormalbreasttissuesfromwomenovertheageof80years
AT sawabemotoji alternativeuseofmultipleexons1ofaromatasegeneincancerousandnormalbreasttissuesfromwomenovertheageof80years
AT araitomio alternativeuseofmultipleexons1ofaromatasegeneincancerousandnormalbreasttissuesfromwomenovertheageof80years
AT akiyamafutoshi alternativeuseofmultipleexons1ofaromatasegeneincancerousandnormalbreasttissuesfromwomenovertheageof80years
AT sakamotogoi alternativeuseofmultipleexons1ofaromatasegeneincancerousandnormalbreasttissuesfromwomenovertheageof80years
AT utsumitoshiaki alternativeuseofmultipleexons1ofaromatasegeneincancerousandnormalbreasttissuesfromwomenovertheageof80years
AT yoshimuranoriko alternativeuseofmultipleexons1ofaromatasegeneincancerousandnormalbreasttissuesfromwomenovertheageof80years
AT haradanobuhiro alternativeuseofmultipleexons1ofaromatasegeneincancerousandnormalbreasttissuesfromwomenovertheageof80years